Consistent with the observation that patients with type 2 diabetes characterized by insulin resistance are at an increased risk of getting AD, not only reductions in insulin levels and insulin receptor expression but also deficient downstream signaling pathways have been reported to occur in brains of AD patients [6]–[9]. The gene discussed is INS; the disease is type 2 diabetes mellitus.